Health News
FDA expands treatment window for use of clot retrieval devices in certain stroke patients
- Details
- Written by YNN YNN
- Published: 16 February 2018 16 February 2018
Washington, DC - The U.S. Food and Drug Administration today cleared the use of the Trevo clot retrieval device to treat certain stroke patients up to 24 hours after symptom onset, expanding the device’s indication to a broader group of patients. This device is cleared for use as an initial therapy for strokes due to blood clots (also known as an acute ischemic stroke) to reduce paralysis, speech difficulties and other stroke disabilities and only as an addition to treatment with a medication that dissolves blood blots called tissue plasminogen activator (t-PA). The device was previously cleared for use in patients six hours after symptom onset.
FSIS Issues Public Health Alert For Poultry Products due to Possible Salmonella Contamination
- Details
- Written by USDA USDA
- Published: 16 February 2018 16 February 2018
Washington, DC - The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert out of an abundance of caution due to concerns about illnesses reported in the state of Iowa that may be caused by Salmonella associated with a chicken salad product. This product was sold at all Fareway grocery stores in Iowa, as well as Illinois, Minnesota, Nebraska and South Dakota.
Accountability report on sugary drinks in America
- Details
- Written by YNN YNN
- Published: 25 December 2017 25 December 2017
Dallas, Texas - American Heart Association CEO Nancy Brown issued the following statement today on the Beverage Calories Initiative report from the American Beverage Association and the Alliance for a Healthier Generation. The American Heart Association, along with the Clinton Foundation, is a co-founder of the Alliance for a Healthier Generation.
FDA funding to promote innovation and broaden patient access through competition Health
- Details
- Written by FDA Commissioner Scott Gottlieb, M.D. FDA Commissioner Scott Gottlieb, M.D.
- Published: 13 February 2018 13 February 2018
Washington, DC - New scientific opportunities, as well as advances in manufacturing and commerce, give the U.S. Food and Drug Administration new ways to advance our mission to protect and promote public health. Leveraging these opportunities requires us to make investments in regulatory science that can reduce uncertainty for innovators, spur investment in new industries and provide principles for the safe and effective development of new technologies. These same advances also give us new ways to support greater availability and use of generic drugs as a way to promote price competition and patient access.
Dance Your Way to Fitness
- Details
- Written by American Cancer Society American Cancer Society
- Published: 25 December 2017 25 December 2017
Yuma, Arizona - So, you think you can dance? You’re probably right! From the Argentine tango to Zumba, hip-hop to the Lindy hop, there’s a style of dance to fit just about any taste.